Related Experiment Video

Updated: Aug 11, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

How to make pancreatic beta cells--prospects for cell therapy in diabetes

Tomer Nir1, Yuval Dor

  • 1Department of Cellular Biochemistry and Human Genetics, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.

Current Opinion in Biotechnology
|August 9, 2005
PubMed

Insights

Enhancing beta cell mass is key for diabetes cure. Adult beta cell proliferation offers a promising avenue for regenerative therapy, potentially using differentiated cells to boost insulin production.

Area of Science:

  • Endocrinology
  • Regenerative Medicine
  • Diabetes Research

Background:

  • Diabetes mellitus is characterized by the loss of insulin-producing beta cells.
  • Cell and regenerative therapies are promising for beta cell replacement.
  • Current beta cell sources (stem cells, transdifferentiation) have limitations.

Purpose of the Study:

  • To explore novel strategies for increasing beta cell mass.
  • To investigate the potential of adult beta cells for therapeutic applications.
  • To identify effective starting materials for beta cell regeneration.

Main Methods:

  • Review of recent findings on beta cell formation.
  • Analysis of physiological mechanisms of beta cell regeneration.
  • Evaluation of potential therapeutic sources for beta cells.

Main Results:

  • Adult beta cell formation primarily occurs through beta cell proliferation.
  • This proliferation mechanism highlights the potential of existing differentiated beta cells.
  • Terminally differentiated beta cells can be a viable source for enhancing beta cell mass.

Conclusions:

  • Beta cell proliferation is the main driver of adult beta cell formation.
  • Terminally differentiated beta cells represent a promising starting material for regenerative therapy.
  • Enhancing beta cell mass through proliferation could be a key strategy for diabetes treatment.

More Related Videos

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice06:57

Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice

Published on: April 10, 2026

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...